Programme

Thursday 11 February 15.00 - 17.15

Session A: HRB Strategy overview

This session will introduce attendees to the new five-year HRB Strategy, taking an in-depth look at several key areas of focus over the next five years.

15.00 - 15.05

Opening and welcome: Dr Mairéad O Driscoll, Chief Executive, Health Research Board

15.05 - 15.25

Keynote: Dr Liisa-Maria Voipio-Pulkki, Director General of Strategic Affairs and Chief Medical Officer, Ministry of Social Affairs and Health, Finland

Data infrastructure and governance in Finland – catalysts for success and advice for Ireland

15.25 - 15.45

Presentation: Dr Mairéad O Driscoll, Chief Executive, Health Research Board

HRB Strategy 2021-2025: General overview

15.45 - 16.00

Break

16.00 - 16.40

Strategy implementation deep dive

A closer look at some of the key areas of focus over the next five years

16.40 - 17.10

HRB Strategy – general discussion 

17.10 - 17.15

Closing remarks: Dr Mairéad O Driscoll, Chief Executive, Health Research Board

Friday 12 February 9.00 - 11.15

Session B: Futureproofing health research

This session will draw upon learnings from the COVID-19 pandemic to address various ways in which researchers can futureproof research projects and grants for unanticipated challenges or events. 

9.00 - 9.05

Opening and welcome: Dr Mairéad O Driscoll, Chief Executive, Health Research Board

9.05 - 9.35

HRB Impact Award

Who won? And a chat about what they’ve done to deserve it

9.35 - 9.55

Keynote: Professor Martin McKee, Professor of European Public Health, London School of Hygiene & Tropical Medicine

A journal of the plague year: reflections on health research in a pandemic

9.55 - 10.10

Break

10.10 - 10.40

Futureproofing research panel:

  • Dr Sara Burke, Research Assistant Professor of Health Policy, School of Medicine, Trinity College Dublin

       Reorienting a research programme to adapt to COVID-19 restrictions

  • Professor Fionnuala Breathnach, Associate Professor of Obstetrics & Gynaecology, Royal College of Surgeons in Ireland

       Ensuring the continuation of a non COVID-19 clinical trial during the pandemic

  • Dr Catherine Gill, Programme Manager, Health Research Board 

10.40 - 11.10

Session Q&A

11.10 - 11.15

Closing remarks: Dr Mairéad O Driscoll, Chief Executive, Health Research Board